In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...
AI in drug discovery is evolving fast. Join the experts behind today’s real progress as they share what works, what doesn’t and what you need to know next.
This article is based on a poster originally authored by Peter Hsueh, Lili Qin, Jane Liu and Wenlin Ren. Target proteins are central to the antibody discovery process. These reagents play a critical ...
This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment ...
Morning Overview on MSN
Chai Discovery lands $130M Series B at a $1.3B valuation
Chai Discovery has just vaulted into the biotech big leagues, securing a $130 million Series B round that values the company ...
AZoRobotics on MSN
BioLizard Awarded Grant from VLAIO to Advance AI-Powered Biomedical Solution for Accelerated Drug Development
BioLizard, a leading bioinformatics, data analytics and data engineering consulting company driving digital transformation in ...
Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...
Prominent companies operating in the global drug discovery services market include: • Charles River Laboratories (US) • Thermo Fisher Scientific (US) • WuXi AppTec (China) • Pharmaron (China) • ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback